The 2023 Deep Brain Stimulation (DBS) Think Tank meeting takes place in Gainesville, FL on August 9-11, 2023 with a theme of “Pushing the forefront of neuromodulation”.
Select recordings will be available for some sessions following the event.
Wednesday, August 9, 2023
1:00 PM – 3:00 PM
Cutting Edge Translational Neuromodulation
Moderator: Aryn Gittis, Ph.D. – Carnegie Mellon University
Circuit-Inspired Strategies to Improve Treatments for Parkinson’s Disease
Aryn Gittis, Ph.D.
Carnegie Mellon University
Modulating neural reinforcement with subthalamic deep brain stimulation in Parkinson’s disease
Wolf-Julian Neumann, M.D.
Charité Berlin
Vagus nerve stimulation to enhance motor learning and myelin repair
Cristin Welle, Ph.D.
University of Colorado
3:00 PM – 3:30 PM
Coffee Break
3:30 PM – 5:30 PM
Cutting Edge Physiology
Moderator: Helen Bronte-Stewart, M.D. – Stanford University
Towards automated, data-driven, Adaptive DBS
Simon Little, Ph.D.
University of California San Francisco
Neural biomarkers of mood: implications for the closed loop debate
Sameer Sheth, M.D. Ph.D.
Baylor College of Medicine
Sensing motion: real time kinematic feedforward and feedback inputs for adaptive DBS
Helen Bronte-Stewart, M.D.
Stanford University
5:30 PM – 6:30 PM
Pre-dinner Break
6:30 PM – 9:30 PM
Dinner & Industry Blitz
Moderator
Alfonso Fasano, M.D.
University of Toronto
- Medtronic
- Boston Scientific
- NeuroPace
- Newronika
- Abbott
- Motif
Thursday, August 10, 2023
10:00 AM – 12:00 PM
Cutting Edge Advances in Europe
Moderator: Huiling Tan, D.Phil. – University of Oxford
Effect of high frequency STN DBS beyond suppression beta and its potential implications
Huiling Tan, D.Phil.
University of Oxford
Do the Parkinsonian Basal Ganglia Dream of Beta Oscillations? Insights from MPTP Non-human Primate Sleep Studies to 24/7 Adaptive DBS
Hagai Bergmann, M.D., Ph.D
The Hebrew University of Jerusalem
Going On with DBS – what needs to be considered when it comes to gait
Monika Pötter-Nerger, M.D.
University Medical Center Hamburg-Eppendorf
12:00 PM – 1:30 PM
Lunch & Networking
1:30 PM – 3:30 PM
Cutting Edge Advances in Asia
Moderator: Valerie Voon, M.D., Ph.D. – University of Cambridge
Intracranial physiological biomarkers of neuropsychiatric symptoms
Valerie Voon, M.D., Ph.D.
University of Cambridge
Combined BNST and NAc stimulation for Treatment refractory depression: chronic recording and clinical results
Bomin Sun, M.D., Ph.D.
Shanghai Jiao Tong University School of Medicine
A variety of clinical responses to thalamic DBS in the individual Tourette syndrome patients
Takashi Morishita, M.D., Ph.D.
Fukuoka University Hospital
4:00 PM – 6:00 PM
Neuroethics Cases: Dilemmas that Inform the Future of Neuromodulation
Moderator: Gabriel Lázaro-Muñoz, Ph.D., J.D. – Harvard University
Life after a beneficial experimental DBS trial: New opportunities and challenges
Gabriel Lázaro-Muñoz, Ph.D., J.D.
Harvard University
Neurotech Justice at the Bedside: Thinking about what we say to patients about technology
Theresa Williamson, M.D.
Harvard University
Keeping the human in the loop: Considerations regarding trust, responsibility and justice
Laura Cabrera, Ph.D.
Penn State University
6:00 PM – 7:00 PM
Dinner & Networking
7:00 PM – 9:00 PM
Keynote Speaker: A somato-cognitive action network alternates with effector regions in motor cortex
Nico Dosenbach, M.D., Ph.D.
Washington University in St. Louis
Friday, August 11, 2023
7:00 AM – 8:00 AM
Breakfast
8:00 AM – 10:00 AM
Cutting Edge Computational Modeling
Moderator: Cameron McIntyre, Ph.D. – Duke University
Clinical Decision Support Systems for DBS
Cameron McIntyre, Ph.D.
Duke University
If Netflix did neuromodulation: a framework for behaviourally driven, scalable programming
Jonathan O’Keeffe, M.D.
Machine Medicine
Empowering Precision Medicine: AI-Driven Medical Imaging for Personalized Clinical Applications
Noam Harel, Ph.D.
University of Minnesota
10:00 AM – 10:30 AM
Coffee Break
10:30 AM – 12:30 PM
Obstacles/Controversies in Neuromodulation and How to Overcome Them
Moderators: Helen Mayberg, M.D. – Icahn School of Medicine at Mount Sinai & Phillip Starr, M.D., Ph.D. – University of California San Francisco
What is the most relevant time scale to measure and treat neural signatures of mood abnormalities?
Helen Mayberg, M.D.
Icahn School of Medicine at Mount Sinai
Andrew Krystal, M.D.
University of California San Francisco
What is the most important feature to put into neurostimulators of the future?
Nader Pouratian, M.D., Ph.D.
University of Texas Southwestern Medical Center
Phillip Starr, M.D., Ph.D.
University of California San Francisco
Andreas Horn, M.D., Ph.D.
Harvard University
12:30 PM – 2:00 PM
Adjourn & Box Lunches